News tagged with clopidogrel
Related topics: patients , heart attack , thrombosis , aspirin , blood clots
Clopidogrel after MI less effective in diabetes patients
(HealthDay)—Clopidogrel therapy following a heart attack does less to reduce the risk of death in patients with diabetes than in those without diabetes, according to a study published in the Sept. 5 issue ...
Diabetes
Sep 05, 2012 |
not rated yet |
0
Aspirin-clopidogrel no better than aspirin alone for patients with lacunar stroke
Aspirin combined with the antiplatelet drug clopidogrel is no better than aspirin alone for stroke prevention in people with a history of lacunar strokes, and the combination carries a greater risk of gastrointestinal bleeding, ...
Cardiology
Aug 29, 2012 |
not rated yet |
0
|
Global platelet reactivity and high risk ACS patients
Global platelet reactivity is more effective than responsiveness to clopidogrel in identifying acute coronary syndrome (ACS) patients at high risk of ischemic events, according to research presented at ESC Congress 2012.
Cardiology
Aug 28, 2012 |
not rated yet |
0
Omission of aspirin from antiplatelet regimen: The WOEST study
Lifelong anticoagulation is necessary for the prevention of stroke in patients with rhythm disturbances and with mechanical valves. Patients who have a coronary stent implanted also need the antiplatelet drugs aspirin and ...
Cardiology
Aug 28, 2012 |
not rated yet |
0
Personalized antiplatelet treatment improves outcome after PCI
Personalized antiplatelet treatment leads to better outcomes than standard antiplatelet treatment in patients undergoing coronary stent implantation, according to results from the MADONNA study presented at ESC Congress 2012.
Cardiology
Aug 28, 2012 |
not rated yet |
0
Prasugrel versus clopidogrel for ACS patients managed without revascularisation
The first trial to study the effect of platelet inhibition in patients with acute coronary syndromes managed medically without revascularisation has found no significant difference between prasugrel and clopidogrel in the ...
Cardiology
Aug 27, 2012 |
not rated yet |
0
Novel anti-platelet therapy reduces risk of cardiac events in patients with history of heart attack
According to new research from Brigham and Women's Hospital (BWH), adding vorapaxar, an investigational platelet blocker, to standard antiplatelet therapy significantly reduces the long-term risk of recurrent cardiovascular ...
Cardiology
Aug 27, 2012 |
not rated yet |
0
Anti-clotting drugs yield similar results
The first trial to study patients with acute coronary syndrome who do not undergo coronary stenting or bypass surgery found no significant difference between two anti-clotting drugs – prasugrel and clopidogrel – in preventing ...
Cardiology
Aug 26, 2012 |
not rated yet |
0
|
Aspirin still first-line therapy for unstable angina/NSTEMI
(HealthDay) -- Aspirin is still the first line of therapy for patients with unstable angina or non-ST-elevation myocardial infarction (NSTEMI), and ticagrelor can be used in place of clopidogrel or prasugrel ...
Cardiology
Jul 17, 2012 |
not rated yet |
0
Updated AHA/ACCF guidelines for unstable angina include newest blood-thinning drug
Ticagrelor, a blood-thinning drug approved by the FDA in 2011, should be considered along with older blood thinners clopidogrel and prasugrel for treating patients who are experiencing chest pain or some heart attacks, according ...
Cardiology
Jul 16, 2012 |
not rated yet |
0
Generic versions of plavix approved
(HealthDay) -- The first generic versions of Plavix (clopidogrel bisulfate) have been approved by the U.S. Food and Drug Administration.
Medications
May 18, 2012 |
not rated yet |
0
Plavix's new generic status could be boon for patients
(HealthDay) -- The blockbuster drug Plavix (clopidogrel), used to prevent clotting in some heart patients, will go off patent in the United States on Thursday, making it considerably more affordable.
Medications
May 15, 2012 |
not rated yet |
0
World's first bedside genetic test gets green light by Lancet
Developed in Canada and conducted by researchers from the University of Ottawa Heart Institute, in partnership with Spartan Bioscience, the world's first bedside genetic test has received acknowledgment by ...
Cardiology
Mar 29, 2012 |
not rated yet |
0
Study reports validation of the first point-of-care genetic test in medicine, regarding use of antiplatelet therapy
A study published Online First by the Lancet reports the successful validation and clinical application of the first point-of-care genetic test in medicine. The test successfully identifies the CYP2C19*2 allele: a common ...
Cardiology
Mar 28, 2012 |
not rated yet |
0
|
The Cardiovascular Research Foundation announces initiation of HORIZONS-AMI II Clinical Trial
The Cardiovascular Research Foundation (CRF) today announced the initiation of the HORIZONS-AMI II randomized trial, evaluating Promus Element platinum-chromium everolimus-eluting stents versus Omega bare-metal stents in ...
Cardiology
Mar 27, 2012 |
not rated yet |
0
